Impact of childhood nephrotic syndrome on obesity and growth: a prospective cohort study
Pediatric Nephrology · 2024-09 · 39 (9) · 2667-2677
DOI: 10.1007/s00467-024-06370-0 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Pediatric Nephrology, online erschienen am 18.04.2024. Verfasst von Cal H Robinson und 17 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, The Hospital for Sick Children, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Nephrotic Syndrome, Pediatric Obesity. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Physicians Services Incorporated (PSI) Foundation, Hospital for Sick Children Research Institute, Canada Research Chairs program.
Abstract (Originalsprache)
BACKGROUND: Children with nephrotic syndrome are at risk of obesity and growth impairment from repeated steroid treatment. However, incidence and risk factors for obesity and short stature remain uncertain, which is a barrier to preventative care. Our aim was to determine risk, timing, and predictors of obesity and short stature among children with nephrotic syndrome. METHODS: We evaluated obesity and longitudinal growth among children (1-18 years) enrolled in Insight into Nephrotic Syndrome: Investigating Genes, Health, and Therapeutics. We included children with nephrotic syndrome diagnosed between 1996-2019 from the Greater Toronto Area, Canada, excluding congenital or secondary nephrotic syndrome. Primary outcomes were obesity (body mass index Z-score ≥ + 2) and short stature (height Z-score ≤ -2). We evaluated prevalence of obesity and short stature at enrolment (< 1-year from diagnosis) and incidence during follow-up. Cox proportional hazards models determined the association between nephrotic syndrome classification and new-onset obesity and short stature. RESULTS: We included 531 children with nephrotic syndrome (30% frequently relapsing by 1-year). At enrolment, obesity prevalence was 23.5%, 51.8% were overweight, and 4.9% had short stature. Cumulative incidence of new-onset obesity and short stature over median 4.1-year follow-up was 17.7% and 3.3% respectively. Children with frequently relapsing or steroid dependent nephrotic syndrome within 1-year of diagnosis were at increased risk of new-onset short stature (unadjusted hazard ratio 3.99, 95%CI 1.26-12.62) but not obesity (adjusted hazard ratio 1.56, 95%CI 0.95-2.56). Children with ≥ 7 and ≥ 15 total relapses were more likely to develop obesity and short stature, respectively. CONCLUSIONS: Obesity is common among children with nephrotic syndrome early after diagnosis. Although short stature was uncommon overall, children with frequently relapsing or steroid dependent disease are at increased risk of developing short stature. Effective relapse prevention may reduce steroid toxicity and the risk of developing obesity or short stature.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Nephrology, The Hospital for Sick Children, Toronto, Ontario, Canada.
- Department of Paediatrics, The University of Toronto, Toronto, Ontario, Canada.
- Child Health Evaluative Sciences, Research Institute, The Hospital for Sick Children, Toronto, Ontario, Canada.
- Division of Nephrology, Department of Pediatrics, McMaster Children's Hospital, Hamilton, Ontario, Canada.
- Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.
- Division of Nephrology, Department of Paediatrics, Montreal Children's Hospital, Montreal, Quebec, Canada.
ORCID-Profile: Cal H Robinson
Förderung
- Physicians Services Incorporated (PSI) Foundation
- Hospital for Sick Children Research Institute
- Canada Research Chairs program
- Cure Glomerulopathy consortium Career Development Fellowship program
- Physician Services Incorporated
- Canada Research Chairs
- Hospital for Sick Children
Zitieren
APA
Robinson, C. H., Aman, N., Banh, T., Brooke, J., Chanchlani, R., Dhillon, V., Langlois, V., Levin, L., Licht, C., McKay, A., Noone, D., Parikh, A., Pearl, R., Radhakrishnan, S., Rowley, V., Teoh, C. W., Vasilevska-Ristovska, J., & Parekh, R. S. (2024). Impact of childhood nephrotic syndrome on obesity and growth: a prospective cohort study. Pediatric Nephrology, 39(9), 2667-2677. https://doi.org/10.1007/s00467-024-06370-0
Vancouver
Robinson CH, Aman N, Banh T, Brooke J, Chanchlani R, Dhillon V, et al. Impact of childhood nephrotic syndrome on obesity and growth: a prospective cohort study. Pediatric Nephrology. 2024;39(9):2667-2677. doi:10.1007/s00467-024-06370-0
BibTeX
@article{Robinson2024,
author = {Robinson, Cal H and Aman, Nowrin and Banh, Tonny and Brooke, Josefina and Chanchlani, Rahul and Dhillon, Vaneet and Langlois, Valerie and Levin, Leo and Licht, Christoph and McKay, Ashlene and Noone, Damien and Parikh, Alisha and Pearl, Rachel and Radhakrishnan, Seetha and Rowley, Veronique and Teoh, Chia Wei and Vasilevska-Ristovska, Jovanka and Parekh, Rulan S},
title = {Impact of childhood nephrotic syndrome on obesity and growth: a prospective cohort study},
journal = {Pediatric Nephrology},
year = {2024},
volume = {39},
number = {9},
pages = {2667--2677},
doi = {10.1007/s00467-024-06370-0}
}
EUVIMED